Home oxygen with high-flow therapy vs standard oxygen for chronic lung and heart disease
Official title: Advanced Bedside Lung Imaging and Respiratory Muscle Monitoring for Respiratory Support Management in Chronically Ill Patients With Acute Respiratory Failure: From Hospital to Home
Run by Università degli Studi di Ferrara · NCT07157696 · Data updated 2026-11-12
In people with long-term lung or heart conditions who need oxygen after leaving the hospital, the study tests whether a high-flow nasal cannula (HFNC) can improve breathing comfort and quality of life compared with standard oxygen therapy.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 80 Years |
| Sex | All |
| Enrollment | 16 (estimated) |
| Sponsor | Università degli Studi di Ferrara Academic / other |
| Locations | 1 site (Ferrara, Italy) |
| Status | Recruiting |
| Started | November 5, 2025 |
| Main results expected | December 31, 2026 |
| Study ends | January 30, 2027 |
| Registry record updated | October 8, 2026 |
| Trial ID | NCT07157696 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18 years or older with chronic respiratory and/or cardiac disease who need long-term oxygen therapy and can manage home devices (with or without a caregiver).
✕Probably not a fit
Patients with very limited life expectancy or those unable to comply with home follow-up may not benefit from this approach.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This trial compares two home oxygen strategies in adults with chronic respiratory or cardiac disease who require long-term oxygen. Participants will alternate two-week periods of HFNC therapy using the myAirvo3 device and standard oxygen therapy, with a short break between periods, to directly compare effects within the same person. Remote monitoring will track oxygen levels, heart rate, symptoms, and sleep to help researchers understand tolerability and potential benefits. A wearable device will monitor night-time breathing pauses and heart rhythm. The study aims to determine whether HFNC provides better comfort and daily functioning than standard oxygen in a home setting.
Why it matters
Potential benefit: If HFNC proves more comfortable and easier to use, patients could experience better breathing relief and quality of life at home.
How similar studies have gone: Previous research in related settings suggests potential advantages of HFNC for comfort and sleep, but results for home oxygen in chronic disease populations are still being explored.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults (≥18 years) with chronic respiratory (e.g., COPD, interstitial lung disease) and/or cardiac disease (e.g., heart failure), * Clinical indication for long-term oxygen therapy, * Capability to manage home-based devices independently or with caregiver assistance * Signed informed consent Exclusion Criteria: * Life expectancy \< 3 months * Inability to comply with home follow-up procedures.
Where it's running
-
Savino SPADARO
Ferrara, Italy, Italy Recruiting
Study contacts
- Study coordinator: Savino Spadaro, Associate professor
- Email: spdsvn@unife.it
- Phone: +393894841243
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Weaning HFNC: When to Stop High-Flow Oxygen in Acute Respiratory Failure
This study tests a protocol to guide when to stop high-flow nasal therapy in adults with acute respiratory failure who are already on HFNC.
-
Turkish version of the S3-NIV questionnaire: testing its reliability for home NIV patients
We’re testing whether the Turkish S3-NIV questionnaire reliably measures how well patients on home non-invasive ventilation can manage daily use and comfort.
-
Extra oxygen during the 6-minute walk for people with chronic respiratory failure or exercise-related low oxygen
This trial will test whether giving extra oxygen during a 6-minute walk helps people with chronic respiratory failure or exertional low oxygen from COPD or interstitial lung disease walk farther, breathe better, and feel easier during the test.
-
Machine learning to detect inspiratory leak in long-term non-invasive ventilation
This project tries to use a machine-learning program to detect inspiratory leaks in people with chronic respiratory failure who use long-term non-invasive ventilation.
-
Monitoring breathing muscle function in ARF patients on non-invasive support
This study tests whether advanced breathing-muscle monitoring can help care teams manage adults with acute respiratory failure who are on non-invasive respiratory support.
-
Comparing 3D/2D electrical impedance tomography and the R/I ratio to measure lung recruitability during mechanical ventilation
This test tries to see if two imaging methods (3D and 2D electrical impedance tomography) and a pressure-based recruitment-to-inflation (R/I) ratio give consistent estimates of how much the lungs can be recruited in sedated adults on mechanical ventilation for acute respiratory failure.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.